Keys To Optimal Selection Of Orthobiologics

Phillip E. Richardson, DPM, Brian T. Dix, DPM, Adebola T. Adeleke, DPM, John M. Baca, DPM, Robert Mendicino, DPM, FACFAS, and Alan R. Catanzariti, DPM, FACFAS

23. Peterson B, Whang PG, Iglesias R, Wang JC, Leiberman JR. Osteoinductivity of commercially available demineralized bone matrix. J Bone Joint Surg Am. 2004;86-A(10):2243-2250.
24. Lee KJH, Roper JG, Wang JC. Demineralized bone matrix and spinal arthrodesis. Spine J. 2005;5(6 Suppl):217s-223s.
25. Martin GJ, Boden SD, Titus L, Scarborough NL. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. Spine. 1999;24(7):637–45.
26. Wang J, Glimcher M. Characterization of matrix-induced osteogenesis in rat calvarial bone defects: I. Differences in the cellular response to demineralized bone matrix implanted in calvarial defects and in subcutaneous sites. Calcif Tissue Int. 1999;65(2):156–65.
27. Wang J, Yang R, Gerstenfeld LC, Glimcher MJ. Characterization of demineralized bone matrix-induced osteogenesis in rat calvarial bone defects: III. Gene and protein expression. Calcif Tissue Int. 2000;67(4):314–20.
28. Watson JT. Overview of biologics. J Orthop Trauma. 2005;19(10 Suppl):S14-S16.
29. Pietrzak WS, Perns SV, Keys J, Woodell-May J, McDonald NM. Demineralized bone matrix graft: a scientific and clinical case study assessment. J Foot Ankle Surg. 2005;44(5):345-353.
30. Rihn JA, Gates C, Glassman SD, Phillips FM, Schwender JD, Albert TJ. The use of bone morphogenetic protein in lumbar spine surgery. J Bone Joint Surg Am. 2008; 90(9):2014-25.
31. Mendenhall S. Bone graft and bone substitutes. Orthopedic Network News. 2008:19(4):18-21. . Published November 10, 2008. Accessed August 5, 2013.
32. Obremskey WT, Marotta JS, Yaszemski MJ, Churchill LR, Boden SD, Dirschl DR. Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics. J Bone Joint Surg Am. 2007; 89(7):1641-9.
33. Flynn JM. Fracture repair and bone grafting. In: Flynn JM (ed): OKU 10: Orthopaedic Knowledge Update. American Academy of Orthopaedic Surgeons, Rosemont, IL, 2011, pp. 11-21.
34. Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 2007;132(7):2412-21.
35. Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology. 2008;134(5):1332-41.
36. Friedlaeder GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S151-158.
37. Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009;302(1):58-66.

Add new comment